Charles River Laboratories International Inc. (CRL)

141.03
NYSE : Commercial Services
Prev Close 146.73
Day Low/High 140.78 / 146.25
52 Wk Low/High 101.58 / 147.72
Avg Volume 395.80K
Exchange NYSE
Shares Outstanding 48.23M
Market Cap 7.08B
EPS 4.70
P/E Ratio 31.97
Div & Yield N.A. (N.A)

Latest News

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Why Charles River Labs Is the Biotech Stock to Buy: Jim Cramer

Ready to diversify your portfolio but unfamiliar with the biotech space? Here's a stock pick from Jim Cramer.

'You Want to Get as Much Lyft as You Can,' When it IPOs, Says Jim Cramer

'You Want to Get as Much Lyft as You Can,' When it IPOs, Says Jim Cramer

Curious about Lyft? Here's what Jim Cramer recommends when the company goes public.

Charles River Laboratories To Present At Raymond James And Barclays Investor Conferences

Charles River Laboratories To Present At Raymond James And Barclays Investor Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: Raymond James 40 th Annual Institutional Investors Conference in Orlando, Florida on Tuesday, March 5 th, at...

Charles River Laboratories Could Suffer a Pullback Before Moving Still Higher

Charles River Laboratories Could Suffer a Pullback Before Moving Still Higher

CRL looks strong and probably capable of further gains but in the short-run we could see a pullback.

Fed Is the Bulls' Friend: Cramer's 'Mad Money' Recap (Tuesday 2/26/19)

Fed Is the Bulls' Friend: Cramer's 'Mad Money' Recap (Tuesday 2/26/19)

Jim Cramer says the fact that Fed Chair Jay Powell knows that things are slowing down may be the best thing this market has going for it.

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2018 Results And Provides 2019 Guidance

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the fourth-quarter and full-year 2018 and provided guidance for 2019.

Charles River Laboratories Signs Binding Offer To Acquire Citoxlab

Charles River Laboratories Signs Binding Offer To Acquire Citoxlab

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has signed a binding offer to acquire Citoxlab for €448 million in cash (or approximately $510 million based on current exchange rates), subject to customary closing...

Charles River Laboratories And Toxys Enter Agreement To Offer ToxTracker® In North America

Charles River Laboratories And Toxys Enter Agreement To Offer ToxTracker® In North America

Charles River Laboratories International, Inc (NYSE: CRL) and Toxys have entered into an agreement to offer access to ToxTracker® in North America.

Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings And 2019 Guidance Release And Conference Call

Charles River Laboratories Schedules Fourth-Quarter 2018 Earnings And 2019 Guidance Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2018 financial results and provide 2019 guidance on Wednesday, February 13 th, before the market opens.

Charles River Laboratories Selected For 2019 Bloomberg Gender-Equality Index

Charles River Laboratories Selected For 2019 Bloomberg Gender-Equality Index

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is pleased to have been selected as one of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI), which distinguishes companies committed to transparency in...

Charles River Laboratories And Atomwise Form A Strategic Alliance To Provide Integrated, Artificial Intelligence-Driven Drug Discovery

Charles River Laboratories And Atomwise Form A Strategic Alliance To Provide Integrated, Artificial Intelligence-Driven Drug Discovery

Charles River Laboratories International, Inc. (NYSE: CRL) and Atomwise, Inc.

Carl Data Pilots Airsafe Sensor With ATCO Wood Products To Help Protect Workers

Carl Data Pilots Airsafe Sensor With ATCO Wood Products To Help Protect Workers

CSE: CRL FSE: 7C5 OTC:CDTAF VANCOUVER, Jan. 7, 2019 /PRNewswire/ - Carl Data Solutions Inc.

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 37 th Annual J.

Carl Data Launches Astra AirSafe Sensor With Multiple Pilots

Carl Data Launches Astra AirSafe Sensor With Multiple Pilots

CSE: CRL FSE: 7C5 OTC:CDTAF VANCOUVER, Dec. 20, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Keep Your Head Up: Cramer's 'Mad Money' Recap (Thursday 12/6/18)

Keep Your Head Up: Cramer's 'Mad Money' Recap (Thursday 12/6/18)

Jim Cramer offers his views on how to hang on in scary markets.

Carl Data Announces Astra Smart Systems And AB Embedded Integration Complete

Carl Data Announces Astra Smart Systems And AB Embedded Integration Complete

CSE: CRL FSE: 7C5 OTC:CDTAF VANCOUVER, Dec. 6, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Carl Data Receives Funding For Further Growth Of Sensor Development Laboratory

Carl Data Receives Funding For Further Growth Of Sensor Development Laboratory

CSE:CRL FSE:7C5 OTC:CDTAF                   VANCOUVER, Nov. 28, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Charles River Laboratories To Present At Evercore ISI Investor Conference

Charles River Laboratories To Present At Evercore ISI Investor Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Evercore ISI HealthConX Conference in Boston on Thursday, November 29 th, at 11:00 a.

Carl Data Moves To Pilot Sanitary Sewer Overflow Forecasting

Carl Data Moves To Pilot Sanitary Sewer Overflow Forecasting

CSE:CRLFSE:7C5OTC:CDTAF VANCOUVER, Nov. 22, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Charles River Laboratories Continues Commitment To Oncology Drug Discovery

Charles River Laboratories Continues Commitment To Oncology Drug Discovery

Charles River Laboratories International, Inc. (NYSE: CRL) today announced new additions to the Tumor Model Compendium.

Charles River Laboratories Announces Third-Quarter 2018 Results

Charles River Laboratories Announces Third-Quarter 2018 Results

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2018.

Carl Data CEO Speaks On Future Of Edge Computing At Inaugural Data Center Summit

Carl Data CEO Speaks On Future Of Edge Computing At Inaugural Data Center Summit

CSE:CRL FSE:7C5 OTC:CDTAF VANCOUVER, Oct. 31, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Charles River To Present Collaborative Methods At Neuroscience 2018

Charles River To Present Collaborative Methods At Neuroscience 2018

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of neuroscience drug discovery experts will present 26 scientific posters, both independently and collaboratively with clients, at Neuroscience 2018, the 48 th annual...

Charles River And Distributed Bio Enter Exclusive Partnership To Create An Integrated Antibody Discovery And Development Platform

Charles River And Distributed Bio Enter Exclusive Partnership To Create An Integrated Antibody Discovery And Development Platform

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has entered into an exclusive partnership with Distributed Bio, Inc.

Carl Data Aligns With Smart City Market Strategist

Carl Data Aligns With Smart City Market Strategist

CSE:CRL FSE:7C5 OTC:CDTA                        VANCOUVER, Oct. 18, 2018 /PRNewswire/ - Carl Data Solutions Inc.

Charles River Laboratories Awarded Five-Year, $95.7 Million Contract By The National Institute Of Allergy And Infectious Diseases

Charles River Laboratories Awarded Five-Year, $95.7 Million Contract By The National Institute Of Allergy And Infectious Diseases

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it was awarded a five-year, $95.

Charles River Laboratories Schedules Third-Quarter 2018 Earnings Release And Conference Call

Charles River Laboratories Schedules Third-Quarter 2018 Earnings Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2018 financial results on Wednesday, November 7 th, before the market opens.

Carl Data Launches Machine Learning Application At Largest North American Water Tech Conference

Carl Data Launches Machine Learning Application At Largest North American Water Tech Conference

CSE:CRL                             FSE:7C5 OTC:CDTA VANCOUVER, Oct. 3, 2018 /PRNewswire/ - Carl Data Solutions Inc.

TheStreet Quant Rating: A (Buy)